GSK brings in zosta lot more cash as drugs giant’s turnover boosted by shingles vaccine and HIV medicines Drugs giant GSK has posted better-than-forecast revenues for the first quarter thanks to strong sales of its shingles vaccine and HIV medicines. The FTSE 100 group saw earnings fall 15 per cent on a constant currency basis to £2.1bn in the first quarter as revenues dropped eight per cent to £7bn after sales of its Covid-19 treatment [...]
GSK coughs up £1.6bn for Bellus as pharma giant boosts its patent medicine cabinet DRUGS GSK plans to buy developer Bellus Health in an all-cash deal for £1.6bn as the drugmaker expands its bet on respiratory therapies.
Astrazeneca’s shares rise, as cancer drug uptake offsets fall in sales of pharma giant’s Covid-19 vaccine Pharma results Astrazeneca has posted what it claimed were “strong” financial results for the full year 2022 as surging demand for cancer medicines offset a fall in Covid vaccine revenues. Shares in Astrazeneca jumped on the news as the firm said it expects another year of double-digit revenue growth in 2023. The British firm’s strong results came [...]
Warning of Lemsip, cough and cold medicine shortage as Brits battle winter flu January 4, 2023 Brits are struggling to get hold of cough and cold medicine as a nasty strain of flu sweeps the nation. It has been reported that there is a shortage of medicines such as throat lozenges, cough mixtures, Lemsip powders and pain killers. This comes after the UK Health and Security Agency issued a warning about [...]
Eyes peeled: Five technologies to watch next year December 27, 2022 The year of the Great Tech Sell-Off is coming to a close. But in this Digital Age, technology is only going to get more exciting, useful, and ethically questionable – so here’s five technologies to watch out for next year. SOLAR Solar power is becoming cheaper, more efficient and increasingly attractive for Brits looking to [...]
Drug developer files patents for cancer treatment which ‘outperforms’ AstraZeneca offering December 20, 2022 Drug development company Nuformix has reformulated and improved one of AstraZeneca’s top cancer drugs, piquing investor interest today. Shares in the London-listed firm jumped nearly a quarter to 35p per share by early afternoon on Tuesday. Nuformix, which focuses on fibrosis and cancer drug repurposing, announced that the drug, known as Olaparib, had “outperformed” AstraZeneca’s [...]
European regulator injects hope into AstraZeneca’s bid to tackle cancer December 19, 2022 The European Medicines Agency has handed AstraZeneca a number of recommendations and one approval for a trio of cancer drugs the Big Pharma firm is looking to market in the continent. AstraZeneca’s cancer drug Enhertu has been given the green light by the European regulator for use among patients with gastric cancer. Around 136,000 cases [...]
Drug developer C4X shares fly after signing £330m AstraZeneca licensing deal November 28, 2022 Drug developer C4X Discovery has signed an exclusive licensing agreement worth up to $402m (£334m) with pharma giant AstraZeneca to develop oral therapy to treat inflammatory diseases. London-listed C4XD’s shares have rocketed this morning, up nearly 40 per cent to 28.5p so far. As part of the deal, C4XD will receive pre-clinical milestone payments worth up [...]
Merck inks £1.1bn deal for cancer drug developer Imago November 21, 2022 American pharmaceutical giant Merck has today inked a $1.35bn (£1.14bn) deal for cancer drug developer Imago BioSciences. The offer of $36 (£30.4bn) a share represents a nearly 107 per cent premium on the company’s last closing price. The deal is intended to bolster Merck’s portfolio of blood disorder treatments, with onlookers expecting the company’s blockbuster [...]
Getting The Care You Need November 17, 2022 | Sponsored Seeking help for your health concern in the right place within the NHS is critical to ensuring you receive the appropriate care at the right time. Practical support and resources are accessible via .nhs.uk to help you find the right first step towards getting the care you need. The online service offers A-Z guides on [...]